| Nom du produit | Pioglitazone |
|---|---|
| Numéro CAS | 111025-46-8 |
| Formule moléculaire | C19H20N2O3S |
| Poids moléculaire | 356.44 |
| Apparence | Poudre cristalline blanche à blanc cassé |
| Essai (HPLC) | ≥98% |
| Perte au séchage | ≤0.5% |
| Résidu au feu | ≤0.1% |
| Métaux lourds | ≤ 10 ppm |
| Point de fusion | 183-186°C |
| Rotation spécifique | N/A (racemic) |
Besoin d'aide ? Contacter notre équipe

Synonymes
Pioglitazone is a thiazolidinedione that has been a cornerstone in type 2 diabetes management for over two decades. It works by targeting PPAR-γ, a nuclear receptor that directly influences insulin sensitivity in adipose tissue, muscle, and liver. Unlike many other antidiabetic drugs that merely stimulate insulin release, pioglitazone addresses the root issue—insulin resistance—helping patients achieve better long-term glycemic control.
For manufacturers, pioglitazone remains a reliable, cost-effective API with a well-established safety profile. We supply pioglitazone as a high-purity crystalline powder, every batch shipped with a full COA, and we offer flexible packaging from 1 kg trial orders to bulk container shipments. Our global logistics network ensures timely delivery to any destination.